Balance Sheet Details (Tables)

9 Months Ended

Sep. 30, 2020

Balance Sheet Related Disclosures [Abstract]

Schedule of Inventory

The following table provides details of our inventory balance (in thousands):

	September 30, 2020
Raw materials	$	391
Work in process	531
Finished goods	88
Total	$	1,010

Details of accrued and other current liabilities

The following table provides details of accrued and other current liabilities (in thousands):

	September 30, 2020		December 31, 2019
Accrued clinical trial expenses	$	13,088	$	18,666
Accrued compensation	8,668		7,179
Other accrued liabilities	10,117		4,074
Common stock warrant liabilities	9		198
Total accrued and other current liabilities	$	31,882	$	30,117